期刊文献+

左卡尼汀联合硫氮酮治疗老年人不稳定型心绞痛疗效观察 被引量:1

Effect of a combination therapy with L-carnitine and diltiazem in the treatment of aged patients with unstable angina pectoris
下载PDF
导出
摘要 目的:观察左卡尼汀联合硫氮酮治疗不稳定型心绞痛(UAP)的疗效。方法:将101例同期收治的老年UAP患者随机分为硝酸甘油组(31例)、左卡尼汀组(28例)及联合用药组(42例),其年龄、性别、病情等无显著差异(P>0.05)。3组均予阿司匹林、肝素、辛伐他汀等基础治疗,硝酸甘油组在此基础上予硝酸甘油10 mg静滴,1次/d;左卡尼汀组予左卡尼汀3.0 g静滴,1次/d;联合用药组予左卡尼汀2.0 g、硫氮酮30 mg静滴,1次/d。3组均连用10 d为一疗程。结果:治疗后左卡尼汀组和联合用药组心绞痛分级症状改善、心电图改善情况及临床症状总有效率分别为92.86%、71.43%、95.23%和89.29%、68.86%、92.85%,均显著高于硝酸甘油组的61.29%、35.48%、64.52,P均<0.05。结论:提示在常规治疗基础上,左卡尼汀联合硫氮酮治疗老年人不稳定型心绞痛可取得明显的效果。 Objective:To evaluate the curative effect of combined use of L-carnitine and diltiazem in aged patients with unstable angina pectoris (UAP). Methods: 101 aged patients with UAP were randomly divided into nitroglycerin group (31 cases), L-carnitine group(28 cases) and combined L-carnitine/diltiazem group (42 ca- ses). Three groups were given elementary treatment with aspirin, heparin and simvastatin. Nitroglycerin group were treated with nitroglycerin, 10 mg iv drip qd; patients of L-carnitine group received L-carnitine,3.0 g, iv drip qd ; and patients of combined group were treated with dihiazem 30 mg, and L-cainitine 2.0 g, iv drip qd. Treatment course was 10 d. Results: The overall effective rates of of combined group and L-carnitine group, in- eluding 3 parameters like improving of angina class, electrocardiograph ( ECG ) and clinical symptom were 92.9%, 71.4% , 95.2% and 89.3% ,68.9%, 92.9%, which were significant higher than that of control group 61.3%, 35.5% and 64.5% (P 〈0.05). Conclusion : There was significant curative effect of L-carni- tine and diltiazem in aged patinets with UAP at the elementary treatment.
出处 《药学与临床研究》 2007年第5期398-400,共3页 Pharmaceutical and Clinical Research
关键词 不稳定型心绞痛 左卡尼汀 硫氮革酮 硝酸甘油 疗效 Unstable angina pectoris (UAP) L-carnitine Diltiazem Nitroglycerin Therapeutic effect
  • 相关文献

参考文献7

二级参考文献14

  • 1陈妙茹 邓斌.左旋肉毒碱治疗冠心病心绞痛疗效观察.实用医学杂志,2000,16(2):183-185.
  • 2高润蒜 吴宁 胡大一.心血管病治疗指南和建议[M].北京:人民军医出版社,2004.1-9.
  • 3Mayer G,Graf H, Legenstein E,et al. L-carnitine substitution in patients on chronicHemodlalysis [J]. Nephron, 1989, 52: 295-299.
  • 4Kobayashi A, Masumura Y, Yamazaki N. L-carnitine treatment for congestive heart failure: experimental and clinical study[J].Japanese Circulation J, 1992,56(1):86-91.
  • 5陈妙茹 邓斌.左肉毒碱治疗冠心病心绞痛疗效观察[J].实用医学杂志社,2000,16(2):183-183.
  • 6Arsenian MA.Carnitine and its derivatives in cardiovascular disease [J].Prog Cardiovas Dis,1997,40(3):265.
  • 7Sassen LM,Bezstavasti K,Vander Giessen WJ.L-propiongl Carnitine in creases postischemic blood flow but does not affect recovery of energy charge [J].AMJ Physiol,1991,26(1pt2):H172.
  • 8Bartels GL,Remme WJ,Se holte HR.Acute myocardial ischemia inducese cardiac carnitine release in man [J].Eur Heart J,1997,18(1):84-90.
  • 9KobayashiA,MasumuraY,YamazakiN,etal.L-carnitine treatment for congestive heart failure: experimental and clinical study[J].Jpn Circ J,1992,56(1):86-94.
  • 10LerchR.The effect of L-carnitine on ischemic heart disease: experimental results[J].Schweiz Rundsch MedPrex,1998,87(4):97-100.

共引文献2697

同被引文献6

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部